100
Participants
Start Date
November 30, 2025
Primary Completion Date
November 30, 2026
Study Completion Date
December 31, 2026
LY3938577
Administered SC
Degludec
Administered SC
Instituto Centenario, CABA
Instituto Médico Catamarca IMEC, Rosario
Accellacare - Wilmington, Wilmington
Tribe Clinical Research, LLC, Greenville
Encore Medical Research, Hollywood
Encore Medical Research - Weston, Weston
Tampa Bay Medical Research, Clearwater
Clinical Research of Central Florida, Lakeland
Holston Medical Group, Bristol
Iowa Diabetes and Endocrinology Research Center, West Des Moines
Washington University School of Medicine, St Louis
AMR Clinical, Norman
Southern Endocrinology Associates, Mesquite
Velocity Clinical Research, Dallas, Dallas
Juno Research, Houston
Consano Clinical Research, LLC, Shavano Park
Texas Valley Clinical Research, Weslaco
Texas Diabetes & Endocrinology, P.A., Austin
Chrysalis Clinical Research, St. George
Tucson Clinical Research Institute, Tucson
Encompass Clinical Research, Spring Valley
University Clinical Investigators, Inc., Tustin
CIPREC, Buenos Aires
Mautalen Salud e Investigación, Buenos Aires
Consultorio de Investigación Clínica EMO SRL, Buenos Aires
Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada, Buenos Aires
Eli Lilly and Company
INDUSTRY